Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Corporativo FraguaB de CVCGSBF 84 PE Ratio without NRI is 12.61 as of Jul. 25, 2026, which is 19% below its 10-year median of 15.51. GuruFocus rates CGSBF with a GF Score™ of 84/100 and a GF Value™ of $44.58. Among 438 Healthcare Providers & Services companies, Corporativo FraguaB de CV ranks better than 89.04% on this metric.
The PE Ratio without NRI, or P/E Ratio without non-recurring items, is a financial ratio used to compare a company's market price to its EPS without NRI. As of today (2026-07-25), Corporativo FraguaB de CV's share price is $29.66448.
Corporativo FraguaB de CV's EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2024 was $2.29. Therefore, Corporativo FraguaB de CV's PE Ratio without NRI for today is 12.61.
During the past 13 years, Corporativo FraguaB de CV's highest PE Ratio without NRI was 28.10. The lowest was 9.39. And the median was 15.51.
Corporativo FraguaB de CV (OTCPK:CGSBF) PE Ratio without NRI Explanation
The PE Ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.
In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio is positive. Also for stocks with the same PE Ratio, the one with faster growth business is more attractive.
If a company loses money, the PE Ratio becomes meaningless.
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio divided by the growth ratio. He thinks a company with a PE Ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio of 20, instead of a company growing 10% a year with a PE Ratio of 10.
Because the PE Ratio measures how long it takes to earn back the price you pay, the PE Ratio can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.
Investors need to be aware that the PE Ratio can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratio s are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio.
Corporativo FraguaB de CV PE Ratio without NRI Related Terms
Corporativo FraguaB de CV PE Ratio without NRI Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Corporativo FraguaB de CV PE Ratio without NRI Chart
Corporativo FraguaB de CV PE Ratio without NRI Competitor Comparison
For the Pharmaceutical Retailers subindustry, Corporativo FraguaB de CV's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Corporativo FraguaB de CV PE Ratio without NRI vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Corporativo FraguaB de CV's PE Ratio without NRI distribution charts can be found below:
* The bar in red indicates where Corporativo FraguaB de CV's PE Ratio without NRI falls into.
Corporativo FraguaB de CV PE Ratio without NRI Calculation
The PE Ratio without NRI, or P/E Ratio without non-recurring items, is a financial ratio used to compare a company's market price to its EPS without NRI. Regular PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than regular PE Ratio.
Corporativo FraguaB de CV's Share Price of today is $29.66448.
For company reported annually, GuruFocus uses latest annual data as the TTM data. Corporativo FraguaB de CV's EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2024 was $2.29.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
There are at least three kinds of PE Ratios used by different investors. They are Trailing Twelve Month PE Ratio, Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio based on inflation-adjusted normalized PE Ratio is called Shiller PE Ratio, after Yale professor Robert Shiller.
In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.
In the calculation of PE Ratio (TTM), the earnings per share used are the earnings per share over the past 12 months.
For Forward PE Ratio, the earnings are the expected earnings for the next twelve months.
For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.
Corporativo FraguaB de CV (CGSBF) has a PE Ratio without NRI of 12.61 as of Jul. 25, 2026. P/E without nonrecurring items is the ratio of share price to a company's earnings less one-time charges. View historical data on Corporativo FraguaB de CV and its competitors. This is 19% below median its historical median of 15.51. Over the past decade, Corporativo FraguaB de CV's PE Ratio without NRI has ranged from 9.39 to 28.10. According to the industry distribution chart, Corporativo FraguaB de CV ranks #48 out of 438 companies in the Healthcare Providers & Services industry, placing it in the top 11%.
Is Corporativo FraguaB de CV's PE Ratio without NRI too high?
Corporativo FraguaB de CV's current PE Ratio without NRI of 12.61 is 19% below median its 10-year median of 15.51. Over the past 10 years, this metric has ranged from a low of 9.39 to a high of 28.10. The Healthcare Providers & Services industry median PE Ratio without NRI is 19.65. Corporativo FraguaB de CV's value of 12.61 is 35.8% below this industry median. Based on the distribution chart, Corporativo FraguaB de CV ranks #48 out of 438 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Corporativo FraguaB de CV has a GF Score™ of 84/100, reflecting its overall financial health beyond just this single metric.
How does Corporativo FraguaB de CV's PE Ratio without NRI compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Corporativo FraguaB de CV ranks #48 out of 438 companies for PE Ratio without NRI. This places Corporativo FraguaB de CV in the top 11% of its industry — outperforming the majority of peers. The industry median PE Ratio without NRI is 19.65. Corporativo FraguaB de CV's value of 12.61 is 35.8% below this benchmark. Historically, Corporativo FraguaB de CV's own PE Ratio without NRI has ranged from 9.39 to 28.10 over the past decade. While the company's 10-year median is 15.51 vs. the industry median of 19.65, Corporativo FraguaB de CV has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PE Ratio without NRI for a Healthcare Providers & Services company?
The median PE Ratio without NRI among Healthcare Providers & Services companies is 19.65, based on 438 companies in the industry. Companies in the top quartile (top 25%) have a PE Ratio without NRI significantly above this median, while those in the bottom quartile fall well below. However, PE Ratio without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Corporativo FraguaB de CV's current PE Ratio without NRI of 12.61 is 35.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PE Ratio without NRI mean?
A high PE Ratio without NRI can signal that a stock is expensive relative to its fundamentals. P/E without nonrecurring items is the ratio of share price to a company's earnings less one-time charges. View historical data on Corporativo FraguaB de CV and its competitors. For the Healthcare Providers & Services industry, the median PE Ratio without NRI is 19.65 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Corporativo FraguaB de CV's current PE Ratio without NRI is 12.61, which is 19% below median its own 10-year median of 15.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Corporativo FraguaB de CV stock overvalued right now?
Corporativo FraguaB de CV (CGSBF) has a current PE Ratio without NRI of 12.61. The stock's GF Value™ is $44.58, compared to a current price of $29.66 — trading 33.5% below its estimated fair value. The current PE Ratio without NRI is 12.61, which is 19% below median its 10-year median of 15.51 and 35.8% below the Healthcare Providers & Services industry median of 19.65. Corporativo FraguaB de CV's overall GF Score™ is 84/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PE Ratio without NRI calculated?
PE Ratio without NRI is calculated from a company's financial statements. For Corporativo FraguaB de CV (CGSBF), the current PE Ratio without NRI is 12.61 as of Jul. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Corporativo FraguaB de CV (CGSBF) Overvalued in 2026?
Based on GuruFocus' analysis, Corporativo FraguaB de CV stock appears to be undervalued.
The current stock price of $29.66 is trading 33.5% below its estimated GF Value™ of $44.58.
Key valuation signals for CGSBF:
PE Ratio without NRI: 12.61 (19% below median its 10-year median of 15.51)
GF Value™: $44.58 vs. price of $29.66 (33.5% below fair value)
Industry Position: 35.8% below the Healthcare Providers & Services median (#48 of 438)
No single metric tells the full story. See the CGSBF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Corporativo Fragua SAB de CV is engaged in the drug retail sector in Mexico. The company operates a network of pharmacies under the SuperFarmacia brand name, focusing on selling medicines, medical devices, and a variety of other products, including grocery items, exercise machines, perfumes, housewares, electronics, personal care products, toys, and photographic equipment.
84GF Score
Get the complete analysis for CGSBF
PE Ratio without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CGSBF has been successfully added to your 
